NET-02 study to open

NET-02:  A multi-centre, randomised, open-label, phase II trial of nanoliposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line […]


Current Clinical Trials – September 2016

The UK, through the National Cancer Research Institute (NCRI) Neuroendocrine Subgroup, is able to offer access to clinical trials to […]


The Core – Derek Butler Three Year Fellowship for Research in the Sphere of Upper GI Tract Diseases and Conditions

September 2016 – Applications are invited for the Core – Derek Butler Fellowship. This is a 3-year full- time fellowship […]